Lymphatic invasion is a significant indicator of poor patient outcome in canine bladder urothelial carcinoma

Nenhuma Miniatura disponível

Data

2021-01-01

Autores

Govoni, Verônica M. [UNESP]
Pigoli, Claudio
Sueiro, Felipe Augusto R.
Zuliani, Fernanda [UNESP]
da Silva, Thayná O. [UNESP]
Quitzan, Juliany G. [UNESP]
Laufer-Amorim, Renee [UNESP]
Grieco, Valeria
Fonseca-Alves, Carlos Eduardo [UNESP]

Título da Revista

ISSN da Revista

Título de Volume

Editor

Resumo

Background: Urothelial carcinoma (UC), also known as transitional cell carcinoma, is the most common malignant tumor of the canine urinary bladder and represents a model for studying human bladder cancer. However, the existing literature has limited data on the clinicopathological characteristics of these tumors and their prognostic value. Aim: The aim of this study was to evaluate such factors, correlating them with follow-up, in a group of 32 dogs with bladder UC. Methods: Clinical data of these cases, submitted to São Paulo State University and VetPat Private Laboratory (São Paulo/Brazil), were recorded between January 2000 and November 2019. For each case, formalin-fixed and paraffinembedded sections were stained with hematoxylin and eosin and histologically evaluated. Survival analysis was carried out, and the prognostic value of the presence of lymphatic invasion and the treatment used was determined. Results: Dogs with neoplastic lymphatic vessel invasion had a lower overall survival compared to those without lymphatic invasion, and dogs that received vinblastine in addition to surgery had higher global survival when compared to animals that received carboplatin in addition to surgery. Conclusion: The results obtained show the importance of further studies regarding the prognostic value of the two factors demonstrated as potential survival predictors, especially the lymphatic vessel invasion.

Descrição

Palavras-chave

Bladder cancer, Dog, Prognosis, Transitional cell carcinoma

Como citar

Open Veterinary Journal, v. 11, n. 4, p. 535-543, 2021.